Shenzhen-based medical devices and reagents manufacturer Shenzhen Living Water POCT Co., LTd (LWPOCT) has reportedly secured RMB 100 million in a Series A financing round. The funding was led by Shenzhen Guochuang Zhiyuan Private Equity Fund Management, Shenzhen Ruihai Private Equity Investment Fund Management, VDO Biotech, Shenzhen Qianhai Zhouyu Investment Partnership Limited, and Qianhai Great Wall Fund Management (Shenzhen) Co., Ltd.
Company Background and Use of Funds
Founded in 2016, LWPOCT is known for its fully automatic rapid diagnostic platform, offering a wide range of products including biochemical diagnosis, chemiluminescence immunodiagnosis, dry immunodiagnosis, all-in-one diagnostics, and molecular diagnostics. The company plans to transition to a Contract Development and Manufacturing Organization (CDMO) business model, providing customized development and services for life science equipment companies. This shift will cover product development, design transformation, product registration, precision manufacturing, after-sales maintenance, and more.-Fineline Info & Tech
